This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cadila Pharmaceuticals Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Sunilkumar Ramsuratbhai Tivari: Innovator in Pharmaceutical Chemistry
Introduction
Sunilkumar Ramsuratbhai Tivari is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on indole-3-carbinol derivatives. His research focuses on developing novel compounds that have potential therapeutic applications.
Latest Patents
One of Tivari's key patents is related to indole-3-carbinol derivatives. The present invention pertains to novel stable indole-3-carbinol derivatives of Formula-I, along with their pharmaceutical compositions and biological activities. This invention includes compositions and methods aimed at the treatment and prevention of conditions associated with inflammation. Tivari holds 1 patent in this area, showcasing his commitment to advancing medical science.
Career Highlights
Sunilkumar Tivari is currently associated with Cadila Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to apply his innovative ideas and research findings in a practical setting, contributing to the development of new therapeutic solutions.
Collaborations
Throughout his career, Tivari has collaborated with esteemed colleagues, including Rajiv Indravadan Modi and Chandan Hardhan Singh. These collaborations have fostered a productive environment for research and innovation, enhancing the impact of their collective work in the pharmaceutical sector.
Conclusion
Sunilkumar Ramsuratbhai Tivari is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new treatments for inflammatory conditions. His innovative spirit and collaboration with industry professionals continue to drive advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
